APO RESEARCH · REPORT
Meglumine
Meglumine is a white crystalline powder. Melting point 128-129°C. Soluble in water, slightly soluble in ethanol, almost insoluble in chloroform. Taste sweet and salty astringent. The molecular formula is C7H17NO5 and the molecular weight is 195.21400. The density is 1.375, the melting point is 128-132ºC and the boiling point is 490.4ºC at 760 mmHg.
Product & engineering
Understand the product.
Meglumine is a white crystalline powder. Melting point 128-129°C. Soluble in water, slightly soluble in ethanol, almost insoluble in chloroform. Taste sweet and salty astringent. The molecular formula is C7H17NO5 and the molecular weight is 195.21400. The density is 1.375, the melting point is 128-132ºC and the boiling point is 490.4ºC at 760 mmHg.
Meglumine is an amino sugar derived from glucose.
Selected research
Industry Research
Meglumine Industry Research Report 2026
Market perspective
Meglumine is a white crystalline powder. Melting point 128-129°C. Soluble in water, slightly soluble in ethanol, almost insoluble in chloroform. Taste sweet and salty astringent. The molecular formula is C7H17NO5 and the molecular weight is 195.21400. The density is 1.375, the melting point is 128-132ºC and the boiling point is 490.4ºC at 760 mmHg.
Meglumine is an amino sugar derived from glucose.
Global Meglumine key players include Merck, Tianma, etc. Global top two manufacturers hold a share about 95%.
Read the full market overview
Europe is the largest market, with a share over 70%, followed by India and North America, both have a share about 15 percent.
In terms of application, the largest application is Contrast agent, followed by Cosolvent, etc.
Report Scope
This report quantifies the global Meglumine market in revenue (US$ million) and, where applicable, sales volume (t), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of types and applications, harmonizes vendor attribution, and presents comparable time series by company, type, application, and region/country, including indicative price bands (US$/t) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for manufacturers, new entrants, channel partners, and investors; the report also reviews technology shifts and notable product introductions relevant to Meglumine.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Meglumine Market by Company
Merck
Tianma
Libang Healthcare Group
New Hualian Pharm
Meglumine Segment by Type
Diatrizoate Meglumine
Lothalamate Meglumine
Lodipamide Meglumine
Meglumine Segment by Application
Cosolvent
Contrast agent
Other
Meglumine Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Meglumine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Meglumine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Meglumine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Meglumine manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Meglumine by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Meglumine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Diatrizoate Meglumine
- Lothalamate Meglumine
- Lodipamide Meglumine
Applications
- Cosolvent
- Contrast agent
- Other
Companies covered
- Merck
- Tianma
- Libang Healthcare Group
- New Hualian Pharm
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Meglumine by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.2.2 Diatrizoate Meglumine
- 2.2.3 Lothalamate Meglumine
- 2.2.4 Lodipamide Meglumine
- 2.3 Meglumine by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Cosolvent
- 2.3.3 Contrast agent
- 2.3.4 Other
- 2.4 Global Market Growth Prospects
- 2.4.1 Global Meglumine Production Value Estimates and Forecasts (2021-2032)
- 2.4.2 Global Meglumine Production Capacity Estimates and Forecasts (2021-2032)
- 2.4.3 Global Meglumine Production Estimates and Forecasts (2021-2032)
- 2.4.4 Global Meglumine Market Average Price (2021-2032)
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Meglumine Production by Manufacturers (2021-2026)
- 3.2 Global Meglumine Production Value by Manufacturers (2021-2026)
- 3.3 Global Meglumine Average Price by Manufacturers (2021-2026)
- 3.4 Global Meglumine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Meglumine Key Manufacturers, Manufacturing Sites & Headquarters
- 3.6 Global Meglumine Manufacturers, Product Type & Application
- 3.7 Global Meglumine Manufacturers Established Date
- 3.8 Global Meglumine Market CR5 and HHI
- 3.9 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Merck
- 4.1.1 Merck Meglumine Company Information
- 4.1.2 Merck Meglumine Business Overview
- 4.1.3 Merck Meglumine Production Capacity, Value and Gross Margin (2021-2026)
- 4.1.4 Merck Product Portfolio
- 4.1.5 Merck Recent Developments
- 4.2 Tianma
- 4.2.1 Tianma Meglumine Company Information
- 4.2.2 Tianma Meglumine Business Overview
- 4.2.3 Tianma Meglumine Production Capacity, Value and Gross Margin (2021-2026)
- 4.2.4 Tianma Product Portfolio
- 4.2.5 Tianma Recent Developments
- 4.3 Libang Healthcare Group
- 4.3.1 Libang Healthcare Group Meglumine Company Information
- 4.3.2 Libang Healthcare Group Meglumine Business Overview
- 4.3.3 Libang Healthcare Group Meglumine Production Capacity, Value and Gross Margin (2021-2026)
- 4.3.4 Libang Healthcare Group Product Portfolio
- 4.3.5 Libang Healthcare Group Recent Developments
- 4.4 New Hualian Pharm
- 4.4.1 New Hualian Pharm Meglumine Company Information
- 4.4.2 New Hualian Pharm Meglumine Business Overview
- 4.4.3 New Hualian Pharm Meglumine Production Capacity, Value and Gross Margin (2021-2026)
- 4.4.4 New Hualian Pharm Product Portfolio
- 4.4.5 New Hualian Pharm Recent Developments
5 Global Meglumine Production by Region
- 5.1 Global Meglumine Production Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.2 Global Meglumine Production by Region: 2021-2032
- 5.2.1 Global Meglumine Production by Region: 2021-2026
- 5.2.2 Global Meglumine Production Forecast by Region (2027-2032)
- 5.3 Global Meglumine Production Value Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.4 Global Meglumine Production Value by Region: 2021-2032
- 5.4.1 Global Meglumine Production Value by Region: 2021-2026
- 5.4.2 Global Meglumine Production Value Forecast by Region (2027-2032)
- 5.5 Global Meglumine Market Price Analysis by Region (2021-2026)
- 5.6 Global Meglumine Production and Value, YOY Growth
- 5.6.1 North America Meglumine Production Value Estimates and Forecasts (2021-2032)
- 5.6.2 Europe Meglumine Production Value Estimates and Forecasts (2021-2032)
- 5.6.3 China Meglumine Production Value Estimates and Forecasts (2021-2032)
- 5.6.4 Japan Meglumine Production Value Estimates and Forecasts (2021-2032)
6 Global Meglumine Consumption by Region
- 6.1 Global Meglumine Consumption Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 6.2 Global Meglumine Consumption by Region (2021-2032)
- 6.2.1 Global Meglumine Consumption by Region: 2021-2026
- 6.2.2 Global Meglumine Forecasted Consumption by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Meglumine Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Meglumine Consumption by Country (2021-2032)
- 6.3.3 United States
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Meglumine Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Meglumine Consumption by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Russia
- 6.4.8 Spain
- 6.4.9 Netherlands
- 6.4.10 Switzerland
- 6.4.11 Sweden
- 6.4.12 Poland
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Meglumine Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Meglumine Consumption by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 India
- 6.5.7 Australia
- 6.5.8 Taiwan
- 6.5.9 Southeast Asia
- 6.6 South America, Middle East & Africa
- 6.6.1 South America, Middle East & Africa Meglumine Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East & Africa Meglumine Consumption by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 Argentina
- 6.6.5 Chile
- 6.6.6 Turkey
- 6.6.7 GCC Countries
7 Segment by Type
- 7.1 Global Meglumine Production by Type (2021-2032)
- 7.1.1 Global Meglumine Production by Type (2021-2032) & (t)
- 7.1.2 Global Meglumine Production Market Share by Type (2021-2032)
- 7.2 Global Meglumine Production Value by Type (2021-2032)
- 7.2.1 Global Meglumine Production Value by Type (2021-2032) & (US$ Million)
- 7.2.2 Global Meglumine Production Value Market Share by Type (2021-2032)
- 7.3 Global Meglumine Price by Type (2021-2032)
8 Segment by Application
- 8.1 Global Meglumine Production by Application (2021-2032)
- 8.1.1 Global Meglumine Production by Application (2021-2032) & (t)
- 8.1.2 Global Meglumine Production Market Share by Application (2021-2032)
- 8.2 Global Meglumine Production Value by Application (2021-2032)
- 8.2.1 Global Meglumine Production Value by Application (2021-2032) & (US$ Million)
- 8.2.2 Global Meglumine Production Value Market Share by Application (2021-2032)
- 8.3 Global Meglumine Price by Application (2021-2032)
9 Value Chain and Sales Channels Analysis of the Market
- 9.1 Meglumine Value Chain Analysis
- 9.1.1 Meglumine Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Meglumine Production Mode & Process
- 9.2 Meglumine Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Meglumine Distributors
- 9.2.3 Meglumine Customers
10 Global Meglumine Analyzing Market Dynamics
- 10.1 Meglumine Industry Trends
- 10.2 Meglumine Industry Drivers
- 10.3 Meglumine Industry Opportunities and Challenges
- 10.4 Meglumine Industry Restraints
11 Report Conclusion
12 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst